samedan logo
 
 
 
spacer
home > pmps > summer 2020 > practical tips to navigate the new normal
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Practical Tips to Navigate the New Normal

The life science sector is in a period of unprecedented transformation. Pharmaceutical manufacturing and packaging businesses have responded swiftly to requirements to pivot their business, producing and packaging new drugs and devices. This is in the context of unparalleled disruption to the supply chain.

The COVID-19 pandemic has accelerated processes throughout the industry. Changes that used to take months or years now take only a few weeks as life science companies support the global effort to find effective treatments for coronavirus SARS-CoV-2.

Every major manufacturer is experiencing disruption across supply chains, driven by volatility in the supply of parts and raw materials. Packaging and labelling sectors have had to respond to an unprecedented acceleration in the pace of change. In the pharma sector, many players have pivoted their operations to join in the race to develop a vaccine or repurpose existing drugs to treat COVID-19. The need to repurpose patient information labelling rapidly to meet regulatory requirements is an immediate challenge.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
Gurdip Singh is CEO of Kallik, the market- leading enterprise labelling company, and a deeply experienced practitioner and leader in life science industry transformation. He previously held senior life science industry leadership roles at CSC, then DXC Technology, and is passionate about the user experience. Over Gurdipís career he has also worked extensively in the healthcare, life science and banking industry, giving him an insight into transferable/cross-industry best practice.
spacer
Gurdip Singh at Kallik
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Northway Biotechpharma and Hansa Biopharma initiate a new Contract Development and Manufacturing project in immunological diseases

Vilnius, Lithuania, and Lund, Sweden - December 20th, 2019 ‚Äď Northway Biotechpharma, a leading biopharmaceutical Contract Development and Manufacturing Organization (CDMO), and Hansa Biopharma, the leader in immunomodulatory enzyme technology for rare IgG-mediated diseases, today announced a new service agreement to develop the next generation of IgG cleaving enzymes.
More info >>

White Papers

Personalised Medicine - Pharma and Dx Firms Share Wider Horizons

DiagnostikNet-BB

Personalised medicine might be a popular catch-phrase at the moment, but the term often causes confusion, as there is still no uniform definition for it. The expression can include areas as diverse as the measurement of individual risk, early detection using biomarker testing, stratification of patients suffering from a disease and predictions about its course.
More info >>

 
Industry Events

World Vaccine Congress Washington

27-29 September 2020, Walter E Washington Convention Center, Washington, US

The World Vaccine Congress is an award-winning series of conferences and exhibitions that have grown to become the largest and most established vaccine meeting of its kind across the globe. Our credibility is show through the prestigious scientific advisory board that spend months of hard work creating a new and topical agenda, year on year.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement